Alzheimer antibody drugs show questionable potential.
Sara
S
Reardon
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000378:metabolism; D016229:Amyloid beta-Peptides / Q000037:antagonists & inhibitors*; D000906:Antibodies / Q000378:metabolism / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic / Q000379:methods; D004345:Drug Industry / Q000379:methods / Q000639:trends; D006801:Humans
D016229:Amyloid beta-Peptides; D000906:Antibodies